Related Experiment Video

Updated: Jul 15, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

Caspase-8 dependent osteosarcoma cell apoptosis induced by proteasome inhibitor MG132

Xiao-Bo Yan1, Di-Sheng Yang, Xiang Gao

  • 1Department of Orthopaedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jie Fang Road, Hangzhou 310009, Zhejiang, PR China.

Cell Biology International
|May 12, 2007
PubMed

Insights

The proteasome inhibitor MG132 effectively induces apoptosis in human osteosarcoma cells by activating caspase-8. MG132 did not affect normal cells, indicating targeted cancer therapy potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Proteasome inhibitors are known to induce apoptosis in various cancer types.
  • The impact of proteasome inhibitors on osteosarcoma cells remains understudied.

Purpose of the Study:

  • To investigate the efficacy of proteasome inhibitor MG132 in inducing apoptosis in human osteosarcoma cells.
  • To elucidate the underlying mechanisms of MG132-induced apoptosis in osteosarcoma.

Main Methods:

  • Treatment of human osteosarcoma MG-63 cells and normal human diploid fibroblast cells with MG132.
  • Cell cycle analysis to detect cell cycle arrest.
  • Reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis to assess protein expression and activation.

Main Results:

  • MG132 induced significant apoptosis in MG-63 cells, with no observed effect on normal fibroblast cells.
  • MG132 treatment led to cell cycle arrest at the G(2)-M phase in MG-63 cells.
  • Increased activation of caspase-8, p27(Kip1) accumulation, and an elevated Bax:Bcl-2 ratio were observed.
  • Activation of caspase-3 and caspase-9 was not detected.

Conclusions:

  • MG132 is a potent inducer of apoptosis in human osteosarcoma cells.
  • The observed apoptosis is dependent on caspase-8 activation and involves p27(Kip1) and Bcl-2 family proteins.
  • MG132 demonstrates selective toxicity towards osteosarcoma cells, suggesting therapeutic potential.

More Related Videos

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...